Q1 FY27 saw 28% YoY revenue growth and 33% higher EBITDA, driven by a shift to high-value products and strong operational discipline. Major CapEx in advanced materials and battery components is underway, with all investments funded by internal accruals.Based on Himadri Speciality Chemical Ltd. [HSC…
Q1 FY27 saw 28% YoY revenue growth and 33% higher EBITDA, driven by a shift to high-value products and strong operational discipline. Major CapEx in advanced materials and battery components is underway, with all investments funded by internal accruals.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.